After the FDA canceled a key advisory meeting, government doctors stepped in to propose a trivalent flu vaccine for the ...

But beware. Health and Human Services Secretary Robert F. Kennedy, Jr. has called for “conflict-free” advisory committee ...

The US Food and Drug Administration on Thursday issued recommendations for the composition of influenza shots for the upcoming respiratory virus season, but without input from its independent vaccine ...

Regenxbio Inc (RGNX) showcases robust financial positioning and strategic progress in gene therapy, despite challenges in ...

Recently announced positive data from pivotal randomized, placebo-controlled phase 3 clinical trial of CAN-2409 in intermediate-to-high risk, ...

Financially, Annexon has a strong cash position, providing a runway of 5-8 quarters, but the stock trades almost at cash due ...

Gemini Bioproducts, LLC ("GeminiBio"), a biopharma and advanced therapy raw materials supplier, and a portfolio company of BelHealth Investment Partners, LLC ("BelHealth"), a Fort Lauderdale-based ...

OS Therapies, Inc. , a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced that it has been awarded a presentation slot at ...

Discover how outsourcing regulatory submission content development improves efficiency and ensures compliance.

The Baloch Liberation Army (BLA) has issued a chilling 48-hour ultimatum to Pakistan, demanding the release of its prisoners or threatening to execute hostages. This comes after Pakistani forces ...

Celltrion Inc. is on a biosimilar roll with the U.S. FDA this month, having gained clearance of Stoboclo and Osenvelt as products referencing Amgen Inc.’s biologic, denosumab (Prolia, Xgeva), along ...

Topline clinical data of the confirmatory registrational study GLOW2 expected in 1Q 2026. GLOW2 study design mirrors GLOW1 study, which met primary endpoint and ...